Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Although sales of X-ray residual stress measurement equipment struggled, deliveries of healthcare equipment and optical application and special-purpose equipment generally remained firm. Personnel expenses increased as the number of hires exceeded the usual level, while contract development projects involving healthcare equipment required more time to resolve issues at the acceptance stage, resulting in more work hours than initially planned.
| Item | Details |
|---|---|
| Net Sales | ¥1,000 million → ¥1,001 million（+0.2%） |
| Operating profit | ¥50 million → ¥-32 million |
| Ordinary income | ¥61 million → ¥-22 million |
| Profit attributable to owners of the parent | ¥46 million → ¥-19 million |
| Net income per share | 33.62 Yen and sen → -14.08 Yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 13 May 2026 |
| Previous-period results | Sales of ¥1,041 million, operating income of ¥89 million, ordinary income of ¥100 million, interim net income attributable to owners of the parent of ¥70 million, and interim earnings per share of ¥51.83 |
| Reason for the revision | Although sales of X-ray residual stress measurement equipment struggled, deliveries of healthcare equipment and optical application and special-purpose equipment generally remained firm. Personnel expenses increased as the number of hires exceeded the usual level, while contract development projects involving healthcare equipment required more time to resolve issues at the acceptance stage, resulting in more work hours than initially planned. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Sales of X-ray residual stress measurement equipment struggled. On the earnings front, personnel expenses increased as the number of hires exceeded the usual level, while contract development projects involving healthcare equipment required more time to resolve issues at the acceptance stage, resulting in more work hours than initially planned.